femoxetine

RN = 59859-58-4 N1 = Piperidine, 3-((4-methoxyphenoxy)methyl)-1-methyl-4-phenyl-, (3R-trans)-
RR = 56222-04-9 (HCl(3R-trans)-isomer)
RR = 85610-75-9 ((3S-cis)-isomer)
SY = FG 4962
SY = FG 4963
SY = FG 8043
SY = FG 8044
SY = femoxitine
SY = trans-(+)-3-((4-methoxyphenoxy)methyl)-1-methyl-4-phenylpiperidine
SY = trans-3-((4-methoxyphenoxy)methyl)-1-methyl-4-phenylpiperidine
SY = femoxetine, hydrochloride, (3S-trans)-isomer
SY = femoxetine, (3S-cis)-isomer
HM = *Piperidines
PI = *ANISOLES (75-80)
PI = ANISOLES (80-82)
SO = Acta Pharm Toxicol (Copenh) 1979;45(4):296
SO = Acta Pharmacol Toxicol (Copenh) 44(3):177;1979
SO = Eur J Pharmacol 42(1):31;1977
SO = Eur J Pharmacol 43:205;1977
SO = J Chromatogr 133(1):147;1977
SO = J Pharm Pharmacol 1979;31(9):638
SO = Life Sci 22:1827;1978
SO = Neuropharmacology 15:665;1976
SO = Neuropharmacology 16:485;1977
SO = Psychopharmacologia 42(1):21;1975
SO = Psychopharmacology 1979;64(2):149
SO = Psychopharmacology 63(3):241;1979
TH = USAN 1982, p.192
PA = Anti-Infective Agents
PA = Antidepressive Agents
PA = Serotonin Uptake Inhibitors
FR = 44
NO = serotonin uptake inhibitor; RN given refers to (3R-trans)-isomer
DA = 19750101
MR = 20011206
UI = C010655

<< Femovan
|
FEMP protocol >>
Copyright-Infos
(Filename: http://www.bfarm.info/fe/femoxetine.htm)